slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 71,011-71,040
Pages 3,679
Rows per page 30
Component
71,011-71,040 of 110,355
12
Includes visual examples of exclusive prints and product packaging.Honest | Investor Conference Presentation Deck | 19 slides · The Honest Company
Conference presentation Investor relations Beat · KPI OverviewLoop · Pareto Focus1 hit
13
Includes a pie chart segment for '28% Sales' and bar charts comparing growth rates.Honest | Investor Conference Presentation Deck | 19 slides · The Honest Company
Conference presentation Investor relations Beat · KPI OverviewLoop · Pareto Focus1 hit
16
Honest | Investor Conference Presentation Deck | 19 slidesHonest | Investor Conference Presentation Deck | 19 slides · The Honest Company
Conference presentation Investor relations Beat · Financial OverviewLoop · Cost Of Inaction1 hit
06
Uses a pyramid framework to segment the fragrance market by value tier.Kering | Mergers and Acquisitions Presentation Deck | 15 slides · Kering
Deck Investment bank Beat · Problem1 hit
08
The slide uses a donut chart visual to represent the sales mix of the portfolio.Kering | Mergers and Acquisitions Presentation Deck | 15 slides · Kering
Deck Investment bank 1 hit
09
The slide uses a three-column layout to present key operational metrics alongside brand imagery.Kering | Mergers and Acquisitions Presentation Deck | 15 slides · Kering
Deck Investment bank 1 hit
11
The slide uses a combination of a biological mechanism diagram, a market data table, and a comparative analysis of current therapy limitations.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
14
Clinical trial baseline data table.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
15
The slide provides a breakdown of patient outcomes including completion and withdrawal reasons.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
19
The chart specifically visualizes IL-6 reduction over time, while the table summarizes max reduction across four markers.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
20
The slide uses individual patient data points (AD-1 to AD-7, HS-1 to HS-12) to show consistent downregulation across cohorts.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
24
The slide uses a comparison table to highlight efficacy metrics (EASI, Pruritus NRS) across different time points and benchmarks.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
26
Data presented across three line charts comparing 'All HS Patients' vs 'Moderate to Severe' subgroups.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
30
The table compares KT-474 (Part C) at Day 28 and 42 against external benchmarks at Week 4. Includes extensive footnote citations.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
32
Data presented as mean change from baseline with 90% CI. Includes table of mean values for delta QTc and absolute QTc.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
35
The diagram illustrates the signaling pathways (TLR, IL-1R, B Cell Receptor) and the specific points of intervention (red asterisks) for the therapy.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
37
The slide outlines a clinical trial design using a dose-escalation process leading to MTD/RP2D expansion cohorts.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
40
The slide uses a split-layout: left side focuses on clinical data (PK/PD/Safety), right side focuses on strategic positioning and clinical development plan.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
44
The slide outlines a standard oncology clinical trial design (3+3 or similar dose escalation) followed by cohort expansion.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
46
Includes a line chart for PK profiles and a table for PK parameters (Cmax, AUClast, Vd, CL, t1/2).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
60
The image shows the Kymera Therapeutics team at their Nasdaq listing event.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
19
The chart shows five distinct growth drivers: Items Completed, Grower Partner Growth, Agency Growth, Farm Management Services Growth, and New Chile Packing House.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
22
The slide uses a simple equation structure (Current State + Fallowing Program = Future EBITDA Goal).Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
37
The slide explains the volatility in revenue through agricultural factors like plant physiology, weather, and supply chain disruptions.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
41
The slide highlights the discrepancy between book value and market value for real estate and agricultural assets.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Action1 hit
47
Includes a detailed amenity legend and project information block.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Action1 hit
64
The slide uses a three-column layout to present distinct categories of future value realization.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Action1 hit
11
The slide highlights sustainability efforts across various LVMH brands.LVMH | ESG Presentation Deck | 33 slides · LVMH
Conference presentation Investor relations Beat · KPIs and TargetsLoop · Cost Of Inaction1 hit
27
The slide outlines four pillars of LVMH's ethics and compliance strategy.LVMH | ESG Presentation Deck | 33 slides · LVMH
Conference presentation Investor relations 1 hit
03
Main Street Capital | Investor Day Presentation Deck | 155 slidesMain Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Problem1 hit